Latest

Interim Results 20-21

13/01/2021

Kromek (AIM: KMK), a worldwide supplier of detection technology focusing on the medical, security screening and nuclear markets, announces its interim results for the six months ended 31 October 2020.

Financial Summary
• Revenue of £4.6m (H1 2019/20: £5.3m)
• Gross margin was 54% (H1 2019/20: 58%; FY 2019/20: 47%)
• Adjusted EBITDA* was £0.9m loss (H1 2019/20: £0.6m loss)
• Loss before tax was £3.4m (H1 2019/20: £2.7m loss)
• Cash and cash equivalents at 31 October 2020 were £5.8m (30 April 2020: £9.4m; 31 October 2019:
£13.4m)

*Adjusted EBITDA is defined as earnings before interest, taxation, depreciation, amortisation, other income
and share-based payments. For further details, see the Financial Review below.

See full interim results here

Kromek’s CEO, Arnab Basu, speaks with London South East, about our substantial revenue growth in H2 2021/22 as trading returns to normal.

  Back to Latest

Related articles

Stay up to date with Kromek news

Subscribe to our newsletter

Unsure what product you need?

Use our Product Finder tool